Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness. - Chou WH; Yan FX; de Leon J; Barnhill J; Rogers T; Cronin M; Pho M; Xiao V; Ryder TB; Liu WW; Teiling C; Wedlund PJ (Journal of clinical psychopharmacology, 2000)